NEW
YORK, July 28, 2023 /PRNewswire/ -- Thorne
HealthTech, Inc. ("Thorne") (the "Company") (NASDAQ: THRN), a
leader in delivering innovative solutions for a personalized
approach to health and wellness, announced today that it will
participate in the Canaccord Genuity 43rd Annual Growth
Conference in Boston.
On Thursday, Aug. 10, at
10:30 a.m. (U.S. Eastern Daylight
Time), Thorne's Chairman and CEO, Paul
Jacobson and the Company's CFO, Saloni Varma, will participate in a fireside
chat. Mr. Jacobson and Ms. Varma will also conduct one-on-one
meetings with investors at the conference.
A live webcast and replay of the panel discussion can be
accessed via the investor section of the Company's website at
investors.thornehealthtech.com.
About Thorne HealthTech
Thorne HealthTech is a leader
in developing innovative solutions for delivering personalized
approaches to health and wellness. As a science-driven wellness
company that empowers individuals with the support, education, and
solutions they need to achieve healthy aging – living healthier
longer – Thorne utilizes testing and data to create improved
product efficacy and to deliver personalized solutions to
consumers, health professionals, and corporations. Predicated on
the power of the individual, Thorne leverages artificial
intelligence models to provide insights and personalized data,
products, and services that help individuals take a proactive and
actionable approach to improve and maintain their health over a
lifetime. Thorne is the only supplement manufacturer that
collaborates with Mayo Clinic on health and wellness research and
content, and is trusted by more than five million customers,
47,000+ health-care professionals, thousands of professional
athletes, more than 100 professional sports teams, and multiple
U.S. National Teams. For more information,
visit Thorne.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/thorne-healthtech-to-participate-in-the-canaccord-genuity-43rd-annual-growth-conference-on-august-10-301887906.html
SOURCE Thorne HealthTech, Inc.